Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04224181 · ClinicalTrials.gov registry record
Inflammation and Cardiovascular Health in Women
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 62
- Enrollment target
NCT04224181: Completed study, sponsored by Massachusetts General Hospital.
NCT04224181 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04224181 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
Study Summary
Systemic immune activation and inflammation are believed to play a significant role in the development and clinical course of myocardial infarction (MI). Among women with HIV (WHIV), heightened systemic immune activation and inflammation persist, even when HIV infection is well-treated with contemporary antiretroviral therapeutic regimens. Moreover, WHIV in high-resource regions face a three-fold increased risk of myocardial infarction as compared with matched non-HIV-infected women. The goals of this study are to better understand ways in which HIV infection-incited systemic immune activation and inflammation augment MI risk among women.
Interventions
- RADIATION Cardiac PET
- RADIATION 99mTc-tilmanocept SPECT/CT
- RADIATION Contrast Enhanced Coronary and Aortic Computed Tomography Angiography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2020-02-03 |
| Est. Completion | 2023-11-09 |
What the finished NCT04224181 record still lists
NCT04224181 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Cardiac PET is the first listed.
NCT04224181 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04224181 about?
NCT04224181 is a clinical study titled "Inflammation and Cardiovascular Health in Women". Systemic immune activation and inflammation are believed to play a significant role in the development and clinical course of myocardial infarction (MI). Among women with HIV (WHIV), heightened systemic immune activation and inflammation persist, even when HIV infection is well-treated with contempo...
What is the current status of trial NCT04224181?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2020-02-03. Estimated completion is 2023-11-09.
What interventions are being tested in trial NCT04224181?
The interventions under investigation include: Cardiac PET (RADIATION), 99mTc-tilmanocept SPECT/CT (RADIATION), Contrast Enhanced Coronary and Aortic Computed Tomography Angiography (RADIATION).
Who is sponsoring clinical trial NCT04224181?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI